Results 1 to 10 of about 1,149,511 (200)

Radiation pneumonitis following Yttrium-90 radioembolization: A Korean multicenter study [PDF]

Frontiers in Oncology, 2023
ObjectiveTo report the incidence of radiation pneumonitis after radioembolization.MethodsIn this retrospective study, from May 2009 to July 2021, 782 consecutive patients underwent radioembolization in two institutes.
Hyo-Cheol Kim, Gyoung Min Kim
doaj   +4 more sources

Radiation recall pneumonitis in the setting of immunotherapy and radiation: a focused review

Future Science OA, 2019
Radiation recall pneumonitis (RRP) is an entity described as pneumonitis localized to a previously irradiated field after exposure to a systemic agent. It has previously been described in the literature in the context of chemotherapeutic agents as well ...
Kerri McGovern, Maged Ghaly, Michael Esposito, Keara Barnaby, Nagashree Seetharamu   +4 more
doaj   +3 more sources

THE INCIDENCE OF RADIATION PNEUMONITIS IN BREAST CANCER PATIENTS WHO RECEIVED RADIOTHERAPY USING 3-DIMENSIONAL TECHNIQUES

Jurnal Kedokteran Diponegoro, 2022
Background: According to the 2018 Global Cancer Observatory from the World Health Organization (WHO), breast cancer is the most common cancer in Indonesia.
Salsabila Lutfiarahma, Yan Wisnu Prajoko, Farah Hendara Ningrum, Christina Hari Nawangsih Prihharsanti   +3 more
doaj   +1 more source

Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers

Frontiers in Oncology, 2021
IntroductionThe present study explores changes in pulmonary function, symptoms and radiological signs of pneumonitis after curatively intended stereotactic body radiation therapy (SBRT).MethodsAll inoperable, early-stage non-small cell lung cancer ...
Janna Berg, Janna Berg, Christina Ramberg, Jon Olav Sulheim Haugstvedt, May-Bente Bengtson, Anne-Marie Gabrielsen, Odd Terje Brustugun, Odd Terje Brustugun, Ann Rita Halvorsen, Ann Rita Halvorsen, Åslaug Helland, Åslaug Helland, Åslaug Helland   +12 more
doaj   +1 more source

Anlotinib helps alleviate radiation pneumonitis: A case report

Precision Radiation Oncology, 2021
Radiation pneumonitis is a serious side effect of thoracic radiotherapy with no established treatment currently. Anlotinib is a small‐molecule tyrosine kinase inhibitor (TKI) with anti‐angiogenic effects.
Jiazhen Chen, Cunliang Wang, Xudong Hu
doaj   +1 more source

Radiation Recall Pneumonitis Induced by Sintilimab: A Case Report and Literature Review

Frontiers in Immunology, 2022
Radiation recall pneumonitis (RRP) is described as an unpredictable acute inflammatory reaction within the previously irradiated lung site during the administration of systematic therapy after radiotherapy. Here, we reported a case of a 54-year-old woman
Min Wang, Shuhui Xu, Hui Zhu
doaj   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

The Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi, Alessandra Ferro, Fabiana Cecere, Daniela Scattolin, Alessandro Del Conte, Alessandro Follador, Sara Pilotto, Valentina Polo, Mariacarmela Santarpia, Rita Chiari, Alberto Pavan, Alessandro Dal Maso, Valentina Da Ros, Giada Targato, Sabrina Vari, Stefano Indraccolo, Fiorella Calabrese, Stefano Frega, Laura Bonanno, Pier Franco Conte, Valentina Guarneri, Giulia Pasello   +21 more
wiley   +1 more source

Clinical outcomes and radiation pneumonitis after concurrent EGFR‐tyrosine kinase inhibitors and radiotherapy for unresectable stage III non‐small cell lung cancer

Thoracic Cancer, 2021
Background Concurrent epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKI) with radiotherapy in patients with EGFR‐mutant unresectable stage III non‐small cell lung cancer (NSCLC) might improve survival. However, both treatments carry a
Kunpeng Xu, Jun Liang, Tao Zhang, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Zefen Xiao, Zhouguang Hui, Jima Lu, Xin Wang, Lei Deng, Wenyang Liu, Jianyang Wang, Yirui Zhai, Jie Wang, Nan Bi, Luhua Wang   +16 more
doaj   +1 more source

Fatal Radiation Pneumonitis: Literature Review and Case Series

Advances in Radiation Oncology, 2020
Purpose: Fatal radiation pneumonitis is a rare event. In recent years, higher incidences of grade 5 pneumonitis have been reported. Based on 3 cases in our clinic, a literature review was performed to assess specific clinical features and risk factors ...
Stephen Keffer, MD, Christopher L. Guy, PhD, Elisabeth Weiss, MD   +2 more
doaj   +1 more source

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities

Radiation Oncology, 2021
Background Patients with lung cancer and interstitial lung disease treated with radiotherapy are at risk of developing radiation pneumonitis. However, the association between interstitial lung abnormalities (ILAs) and radiation pneumonitis in patients ...
Haruki Kobayashi, Kazushige Wakuda, Tateaki Naito, Nobuaki Mamesaya, Shota Omori, Akira Ono, Hirotsugu Kenmotsu, Haruyasu Murakami, Masahiro Endo, Hideyuki Harada, Yasuhiro Gon, Toshiaki Takahashi   +11 more
doaj   +1 more source